Insights

March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn.

San Fransisco – Jan. 27, 2024: A Crowell team successfully advised Iron Health in its acquisition by digital health startup Metronomic. Iron Health was founded over two years ago with an important mission: partner with OB/GYNs to address gaps in women’s health care through innovation. Since its founding, Iron Health built a novel model of care that provides accessible, equitable, quality women’s health care through a virtual care technology platform and multidisciplinary care team— all knitted into the trusted relationship women have with their OB/GYN. Through a strong track record of commercial partnerships across six states, Iron Health was able to provide access to more than 1 million women in the form of 4,000 patient visits, including behavioral health, weight management, nutrition, gestational diabetes, primary care, and menopause services.

San Francisco - November 22, 2024: Crowell & Moring advised Anitian, a leading provider of compliance automation solutions, on a $7 million Series D funding, led by Sageview Capital and with participation by Forgepoint Capital. This funding enables Anitian to accelerate the development of new innovations, including AI-driven automation features and an accredited Platform-as-a-Service (PaaS). Together, these features reduce the time and cost of achieving FedRAMP and CMMC compliance for Cloud Service Providers (CSPs) and the Defense Industrial Base (DIB). The most recent financing brings Anitian’s total funding to more than $50 million.

Antares, a nuclear energy start-up headquartered in Redondo Beach, CA, has successfully raised $30 million in Series A financing, bringing their total capital raised to over $38 million. The funding round was co-led by Alt Cap and Caffeinated Capital, with participation from several other investors, including Rogue, Uncommon Capital, Shrug, Banter Capital, Box Group and Shine Capital. This investment will enable Antares to expand its R&D and manufacturing capabilities to support the demonstration of its first microreactor.

Washington – January 10, 2022: Crowell & Moring represented the founders of Aerial Armor in the sale of the company to Dedrone Holdings Inc., a leader in smart airport security.

San Francisco – October 20, 2022: A cross-practice Crowell & Moring team represented Astra, a leading provider of advanced bank-to-bank transfer technology for financial institutions, fintech startups, and enterprises, in closing a $10 million Series A financing and securing a $30 million line of credit. The financing will support the growth of Astra’s team — with a particular focus on engineering and compliance resources — to further enable faster payments from all sources to any destination.

San Francisco–June 16, 2022: Crowell & Moring’s Emerging Companies & Venture Capital team advised Marshall Wace, a global alternative asset manager, in its investment in Elektrofi’s Series B venture capital financing transaction. The deal, which closed on May 27, marks the latest in a growing number of successful venture investment representations on behalf of Marshall Wace. With this investment, Marshall Wace continues its healthcare crossover fund strategy, which has focused on innovative developers of new biotechnology, medical device applications, and more.

Los Angeles, CA –March 28, 2022: The closing of Crowell & Moring client Firefly Aerospace’s $75 million Series B preferred equity issuance and the secondary sale of Noosphere Venture Partners’ equity in Firefly to AE Industrial Partners LLP (AEI) was announced. The transaction values Firefly above its May 2021 Series A valuation of more than $1 billion. These two transactions constitute a change of control of the company, as well as providing Firefly with the resources to deliver new innovations in space launch vehicles.

San Francisco—September 15, 2021: On September 8, 2021, InBrace, a dental company focused on teeth straightening, announced the closing of an oversubscribed $102 million Series D financing. Crowell & Moring represented co-lead investor Marshall Wace, a global alternative investment manager, in the transaction.  InBrace intends to use proceeds of the Series D financing to accelerate growth by expanding its sales force, launching new marketing initiatives, and driving further support and integration with new and existing orthodontic providers across the country.

San Francisco—September 14, 2021: Crowell & Moring represented Honeywell in its multimillion-dollar investment in Alder Fuels, a cleantech company that is pioneering first-of-its-kind technologies for producing sustainable aviation fuel (SAF) at scale by converting abundant biomass, such as forest and crop waste, into sustainable low-carbon, drop-in replacement crude oil that can be used to produce aviation fuel. 

San Francisco – July 6, 2021: Crowell & Moring client FightCamp, the at-home Boxing and Kickboxing leader in connected fitness, raised $50 million in a Series B funding backed by a group of celebrity investors and venture capitalists. With the funds, FightCamp plans on expanding to the Android platform, launching internationally, and increasing the depth of its interactive content to help users dive deeper into the sport of boxing, kickboxing, and martial arts.

San Francisco – June 7, 2021: Crowell & Moring represented venture capital fund client Konvoy Ventures in six equity investments set to turbo-charge the gaming space.